Nuvectis Pharma's total assets for Q4 2024 were $18.61M, an increase of 7.51% from the previous quarter. NVCT total liabilities were $8.89M for the fiscal quarter, a 40.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.